Join OBIO on Tuesday, June 26th to identify non-dilutive funding programs, learn to prepare your applications, and what you should be aware of after being awarded. Sign up for one or all of four sessions designed to help you build your early-stage strategy toolbox.
On June 25th, join OBIO for a unique opportunity to hear from experienced investors and analysts about how VCs think about valuation and how valuation is translated into deal structure.
Find out more about:
ROI needed for investors
Valuation methods commonly used
Criteria for selecting comparable companies
Characteristics of equity and debenture instruments
Consequences of dilution and follow-on investment
Calculating exit payouts
Red flags and how to prepare to discuss valuation with investors
Get behind-the-scenes on the recent changes at the FDA and learn more about how regulatory process changes affect your company:
Understand FDA’s vision and approach to driving innovation under Commissioner Dr. Scott Gottlieb, and how recent changes in the agency will affect premarket submissions and inspections.
Learn how and when you should be engaging with the FDA.
Find out what the FDA is looking for in 510(k), DeNovo, and PMA submissions & recent approvals of devices with AI and machine learning features.
Join OBIO on Tuesday, June 12th to hear from industry experts on the importance of strategic marketing for health science companies, featuring our keynote speaker, Dr. Brian Jahns, the Senior VP, Commercial and Business Development at Trillium Therapeutics Inc. where he is responsible for providing commercial input clinical and regulatory strategy, as well as carrying out business development activities. Dr. Jahns will discuss why it’s critical for early stage health science companies to develop a strategic plan, the impact of those plans on successful commercialization and lessons learned from his experience in the health science industry.
If you are heading to RESI or BIO in Boston, please join Gail Garland, OBIO CEO, for dinner and an opportunity to network and exchange notes with fellow OBIO companies. Adam Buckley, VP of Business Development, VBI Vaccines and OBIO Board Director, will speak about the VBI Vaccines story.
Deadline to apply: February 5, 2018
The Export Services Branch (ESB), Ontario Ministry of International Trade (MIT) is organizing a Trade Mission to the BIO 2018 International Convention and Business Partnering Forum in Boston, one of the world’s premier biotech partnering events.
The HTLH Conference participants include a large number of prominent senior level decision makers in the following categories:
- Payers, Providers & Employers - 35%
- Investors - 20%
- Media - 15%
- Startups - 10%
- Pharma - 10%
- Government - 10%
On May 3, OBIO welcomed health science leaders, CEOs and the investment community to the tenth annual OBIO Leadership Event. Hosted at SPiN, the event also saw the launch of Use It or Lose It: Industry Solutions to Ontario's Commercialization Gap, OBIO's 2018 Industry Report. Check out the event photo gallery and recap.
Bloom Burton is hosting its seventh annual Healthcare Investor Conference on May 2 and 3, 2018, at the Sheraton Centre Toronto Hotel, Toronto, hosting approximately 60 of Canada’s premier publicly-traded and venture-backed private companies together with the most promising pre-venture companies in the healthcare industry.
Get an in-depth view of the attractive non-dilutive funding programs offered by CQDM which have supported several Ontario health science companies.
✓ Quantum Leap & SynergicQc Programs
✓ Application & Funding Process
✓ Mentorship & Large Pharma Partners
The McMaster Health Sciences Venture Fair features top McMaster health science researchers pitch their novel ideas to venture capital investors. A networking lunch and roundtable session with Q&A is included, with questions answered by the investors themselves. The event is followed by an afternoon reception.
Keynote Speaker: Dr. Brian Lichty, PhD
Senior VP of Basic Research at Turnstone Biologics,
Associate Professor, Pathology & Molecular Medicine at McMaster
OBIO will be hosting Pfizer Global at ONRamp (100 College Street, Suite 158) for a workshop and partnering day. Representatives from Pfizer Global will be present to discuss Pfizer’s partnering philosophy, as well as the interests of individual research units. They will also discuss Pfizer’s unique approach to drug discovery. Following the workshop and Q&A session, there is also the opportunity to meet one-on-one with a Pfizer representative to discuss potential partnering opportunities. If interested, please register by March 14th, and request a one-on-one as part of the registration process.
U of T Department of Chemical Engineering & Applied Chemistry: 2nd annual ChemE Exhibition & 33rd ChemE Dinner
Special talk given by
Professor Tim Bender
4:00pm – 5:00pm
Poster Gallery and Cocktail Reception
5:00pm – 6:45pm
33rd ChemE Dinner
7:00pm – 9:30pm
OBIO is partnering with NRC-IRAP’s Biomedical Sector Team on a workshop on how Canadian companies and researchers can access funding, directly or indirectly, from the US National Institutes of Health (NIH).
This interactive workshop will help with business plan development through key learnings such as:
Gathering and using decision making analytics
Business plan components and prioritization
Raising capital for early stage health science companies
Join OBIO® on Tuesday, February 6th for a seminar delivered by Professional Coaches and Digital/Strategic Marketing experts.
The Canadian Global Initiative Against Alzheimer's Disease presents the 2nd Alzheimer's Awareness Gala
Monday, December 18, 2017
5:30pm - 10pm
Fairmont Royal York, Toronto, Ontario
This years' keynote speakers include Dr. Serge Gauthier, Dr. Michael Gold, and Prof K. Yogesan.
- Dr. Gauthier, C.M., MD, FRCPC, is the Director of the Alzheimer's Disease Research Unit, McGill University Research Centre for Studies in Aging.
- Dr. Gold is Vice-President, Development Neurosciences, at AbbVie.
- Professor Yogesan is a Professor at the School of Medicine, University of Notre Dame, and a Visiting Scholar at Harvard University.
Keynote speaker, David Rosenberg, Chief Economist, Gluskin Sheff + Associates, will be speaking about 'Living with Lower for Longer', the event will be in support of research on the impact of Age-Related Macular Degeneration (AMD) by Dr. Shelley Boyd, CEO of Translatum Medicus.
Monday December 4th, 2017
Hosted at JLabs Toronto
On November 23rd, Tanja Dowe, CEO, and Tom Gibbs, Director, of Debiopharm Innovation Fund S.A will be in attendance to give an overview presentation about their company's key areas of interest and to meet 1-on-1 with companies that have been accepted after applying online.
Join us for an expert-led overview of what you need to know in order to market drugs in the U.S. while being FDA compliant. This webinar features leading regulatory attorneys from Hyman, Phelps & McNamara (HMP), who will provide an overview of FDA laws, what typically foes wrong in regulatory strategies and submissions, and best practices to ensure you stay on the market in the U.S. and remain compliant with applicable laws. Leading regulatory attorneys from Torys LLP will also provide a Canadian law perspective.
Joel Ironstone is a medical technology development expert with over 15 years of consulting experience developing novel medical technologies. His experience includes technical development, regulatory approvals and the design and execution of clinical trials.
Presented by Bausch + Lomb
Bausch + Lomb is a subsidiary division of the multinational specialty pharmaceutical company, Valeant Pharmaceuticals International, located in Quebec, Canada. B+L operates within the health care and optics space, with a major focus on marketing, sales and distribution of vision care products.
Looking for the latest funding programs or a valuable partnership? Go beyond combing websites and come to OBIO's “Meet the Non-Dilutive Money!”
Representatives will be Live & In Person from:
- Ontario Centres of Excellence (OCE)
- Ontario Genomics Institute (OGI)
Co-Organized by the Ontario Ministry of International Trade & Japan External Trade Organization (JETRO), this webinar will help participants take advantage of the opportunities in Japan’s healthcare market, focusing on medical devices and healthcare IT sectors.